Yes the writing is on the wall for this company , as reflected in the share price , investors believed in them , invested money in them , but company failed to get the new dura brakes in the market within its self imposed timeline due to quality control issues , result is the pathetic revenue figures in the quarterly .
So really a double wammy , running at a loss , can be forgiven if sales are increasing substantially , in this case receipts in the last quarter were only $1.9M against the last nine months of $6.5M and a near $600K loss .
Would like to think it could be turned around by changing management or the board , but possibly too far gone for even that, best option would be sell the tech to a larger company, that can internalise the current pigs in the trough board and management admin costs and then this company would then still have some value as a shell .
- Forums
- ASX - By Stock
- ABV
- Ann: Market Update - Successful Terra Dura Dust Ingress Testing
Ann: Market Update - Successful Terra Dura Dust Ingress Testing, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ABV (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.70M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.9¢ | $21.08K | 235.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 109181 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 131787 | 0.012 |
1 | 100000 | 0.010 |
1 | 700561 | 0.009 |
2 | 10000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 371498 | 2 |
0.015 | 528000 | 2 |
0.016 | 119374 | 2 |
0.017 | 687500 | 3 |
0.019 | 575000 | 1 |
Last trade - 13.20pm 25/11/2024 (20 minute delay) ? |
Featured News
ABV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online